MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS

MBFD, ALSO KNOWN AS NON-INVASIVE PRENATAL TESTING (NIPT), IS A REVOLUTIONARY PRENATAL SCREENING TECHNIQUE THAT ANALYZES DNA FRAGMENTS CIRCULATING IN A PREGNANT WOMAN BLOOD. THIS DNA, WHICH ORIGINATES FROM THE PLACENTA, OFFERS INSIGHTS INTO THE GENETIC MAKEUP OF THE DEVELOPING FETUS. WHILE TRADITIONALLY USED TO DETECT CHROMOSOMAL ABNORMALITIES LIKE DOWN SYNDROME, MBFD IS NOW BEING EXPANDED TO IDENTIFY MICRODELETIONS. THESE ARE SMALL, MISSING SEGMENTS OF DNA THAT CAN LEAD TO VARIOUS GENETIC DISORDERS, INCLUDING INTELLECTUAL DISABILITY, HEART DEFECTS, AND FACIAL FEATURES. MBFD WITH MICRODELETIONS PROVIDES EXPECTANT PARENTS WITH EARLIER AND MORE ACCURATE INFORMATION ABOUT THEIR BABYS GENETIC HEALTH, ENABLING THEM TO MAKE INFORMED DECISIONS ABOUT THEIR PREGNANCY AND FUTURE CARE.